Lars Christian Lund (Lars C Lund)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Venous Thromboembolism

Coronavirus Disease

Cross Sectional

Top Venues

Pharmacoepidemiology and drug safety

Acta psychiatrica Scandinavica

Diabetes, obesity & metabolism

Basic & clinical pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Helene Kildegaard, Rikke Wesselhoeft, Lars Christian Lund, Mette Bliddal
Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adults. Acta psychiatrica Scandinavica (2024)
Helene Kildegaard, Rikke Wesselhoeft, Lars Christian Lund, Mette Bliddal
Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adults. Acta psychiatrica Scandinavica 150 (3) (2024)
Thomas Delvin, Sofie D Egsgaard, Nina Sahlertz Kristiansen, Helene Kildegaard, Lars Christian Lund, Martin Torp Rahbek
Is the sequence ratio an unbiased estimate of the incidence rate ratio? A simulation study. Pharmacoepidemiology and drug safety 33 (3) (2024)
Lars Christian Lund, Patricia Hjorslev Jensen, Jesper Hallas, Morten Andersen, Nicole L Pratt, Nina Sahlertz Kristiansen
Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis. Diabetes, obesity & metabolism (2023)
Martin Torp Rahbek, Lars Christian Lund, Nina Sahlertz Kristiansen
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrhea. Pharmacoepidemiology and drug safety (2023)
Marie Krab Lund, Mikkel Hojlund, Lars Christian Lund
Smoking and severe mental illness: Drawing inference on the directionality of the association requires careful consideration of the temporality of the data. Acta psychiatrica Scandinavica (2023)
Lars Christian Lund, Patricia Hjorslev Jensen, Jesper Hallas, Morten Andersen, Nicole Pratt, Jesper Hallas
Identifying diabetogenic drugs using real world healthcare databases: a Danish and Australian symmetry analysis. Diabetes, obesity & metabolism (2023)
Martin Torp Rahbek, Nina Sahlertz Kristiansen, Lars Christian Lund
Trend adjustment of the sequence difference when performing sequence symmetry analyses. Pharmacoepidemiology and drug safety (2023)
Lars Christian Lund, Martin Torp Rahbek, Peter Brown, Niels Obel, Jesper Hallas, Henrik Frederiksen
Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study. European journal of haematology (2023)
Thomas Delvin, Anette Bygum, Lars Christian Lund, Jacob Harbo Andersen, Nina Sahlertz Kristiansen
Application of the waiting time distribution in a nationwide screening of real-world dermatology drug utilization for aberrant use patterns. Pharmacoepidemiology and drug safety (2023)
Per Damkier, Jesper Hallas, Nina Sahlertz Kristiansen, Jesper Hvass Schmidt, Louise Ladebo Rasmussen, Peter Bjødstrup Jensen, Lars Christian Lund
Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA-1273: A Danish Population-Based Cohort Study. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023)
Lars Christian Lund, Nina Sahlertz Kristiansen
Recommendations on the calculation of confidence intervals for sequence symmetry analyses. Pharmacoepidemiology and drug safety (2022)
Lars Christian Lund
Bayesian symmetry analysis. Pharmacoepidemiology and drug safety 31 (9) (2022)
Lars Christian Lund, Nina Sahlertz Kristiansen, Shirley V Wang
Online tool to create publication ready graphical depictions of longitudinal study design implemented in healthcare databases. Pharmacoepidemiology and drug safety 30 (7) (2021)
Lars Christian Lund, Mikkel Højlund, Daniel Pilsgaard Henriksen, Nina Sahlertz Kristiansen, Kasper Bruun Kristensen
Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis. Pharmacoepidemiology and drug safety 30 (10) (2021)
Kasper Bruun Kristensen, Daniel Pilsgaard Henriksen, Nina Sahlertz Kristiansen, Jesper Hallas, Lars Christian Lund
Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis. Diabetologia 64 (7) (2021)
Andreas Ludvig Ohm Svendsen, Peter Skov Esbech, Emma Nielsen, Nina Sahlertz Kristiansen, Lars Christian Lund
Does administration of vaginal estrogens increase the risk of venous thromboembolism: A case-control study. Basic & clinical pharmacology & toxicology 129 (5) (2021)
Lars Christian Lund, Mikkel Højlund, Daniel Pilsgaard Henriksen, Nina Sahlertz Kristiansen, Kasper Bruun Kristensen
RE: Gout and sodium-glucose cotransporter-2 inhibitors. Pharmacoepidemiology and drug safety (2021)
Lars Christian Lund, Kasper Bruun Kristensen, Mette Reilev, Steffen Christensen, Reimar Wernich Thomsen, Christian Fynbo Christiansen, Eeva-Liisa Røssell Johansen, Nanna Borup Johansen, Nikolai Constantin Brun, Nina Sahlertz Kristiansen, Jesper Hallas
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study. PLoS medicine 17 (9) (2020)
Ann-Cathrine Dalgård Dunvald, Daniel Pilsgaard Henriksen, Nina Sahlertz Kristiansen, Mette Marie Hougaard Christensen, Lars Christian Lund
Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis. European journal of clinical pharmacology 76 (5) (2020)
Mikkel Hojlund, Lars Christian Lund, Jonas Leander Emming Herping, Maija Bruun Haastrup, Per Damkier, Daniel Pilsgaard Henriksen
Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study. BMJ open 10 (8) (2020)